GFM
BIOA

GF Fund Management’s BioAge Labs BIOA Stock Holding History

GF Fund Management’s Portfolio BIOA Stock Details BIOA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$22.6K Buy
921
+124
+16% +$2.24K ﹤0.01% 476
2026
Q1 		$13.9K Buy
797
+93
+13% +$1.79K ﹤0.01% 532
2025
Q4 		$9.31K Buy
+704
New +$6.24K ﹤0.01% 580

Other funds holding BIOA

ACM
AH Capital Management Menlo Park, California $14.2B AUM 20.01% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
OCA
Octagon Capital Advisors New York $1.11B AUM 866.76% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.64B AUM 245.64% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PCH
Polar Capital Holdings London, United Kingdom $42.4B AUM 181.11% 1-Year Est. Return

GF Fund Management's BIOA Position: Q2 2026 in Review

GF Fund Management increased its BioAge Labs (BIOA) stake by 16% in Q2 2026, buying an estimated $2.24K and bringing the position to 921 shares worth $22.6K. The position accounts for ﹤0.01% of the portfolio, ranked #476.

GF Fund Management first reported a position in BIOA in Q4 2025 and has held it in 3 quarters since. 151 funds tracked by Wall St. Rank hold BIOA as of Q2 2026.

  • GF Fund Management held 921 shares of BioAge Labs worth $22.6K as of Q2 2026.
  • GF Fund Management bought 124 BioAge Labs shares in Q2 2026, an estimated $2.24K.
  • BioAge Labs made up ﹤0.01% of GF Fund Management's portfolio in Q2 2026, its #476 holding.
  • GF Fund Management first reported a position in BioAge Labs in Q4 2025 and has held it in 3 quarters since.
  • 151 funds tracked by Wall St. Rank held BioAge Labs as of Q2 2026.

Based on GF Fund Management's 13F filing for Q2 2026, filed 7 Aug 2026.